Single‐microglia transcriptomic transition network‐based prediction and real‐world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease
Jielin Xu(Cleveland Clinic), Feixiong Cheng(Cleveland Clinic Lerner College of Medicine), Yishai Shimoni(Open University of Israel), Ehud Karavani(IBM Research - Haifa), Michael M. Danziger(IBM Research - Haifa), Wenqiang Song(Vanderbilt University), Jianying Hu(IBM (United States)), James B. Leverenz(University of Washington), Jeffrey L. Cummings(University of California, Los Angeles), Xin Chen(Qingdao University), Andrew A. Pieper(Cornell University), Chengxi Zang(Cornell University), Yadi Zhou(Cleveland Clinic Lerner College of Medicine), Fei Wang(Jiading District Central Hospital), Zhenxing Xu(Cornell University), Chang Su(Temple University), Yichen Li(Hebei Medical University), Dhruv Gohel(Maharaja Sayajirao University of Baroda), Michal Rosen‐Zvi(IBM Research - Haifa), Isabela Rivera Paz(Cleveland Clinic Lerner College of Medicine), Yuan Hou(Cleveland Clinic Lerner College of Medicine)
Cited by 13
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
Analysis of shared heritability in common disorders of the brain
|Science|2018|2k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k